# FDA Inspection 1197691 - Oklahoma Blood Institute Arkansas Blood Institute - North Little Rock - January 25, 2023

Source: https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute-arkansas-blood-institute-north-little-rock/cc5162a0-d99f-4aa2-b39b-65fdfd4f6763
Source feed: FDA_Inspections

> FDA Inspection 1197691 for Oklahoma Blood Institute Arkansas Blood Institute - North Little Rock on January 25, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1197691
- Company Name: Oklahoma Blood Institute Arkansas Blood Institute - North Little Rock
- Inspection Date: 2023-01-25
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1197691 - 2023-01-25](https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute-arkansas-blood-institute-north-little-rock/42da9b1a-31ac-4278-95a5-757cc10961c7)
- [FDA Inspection 1081258 - 2019-02-08](https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute-arkansas-blood-institute-north-little-rock/a523f0a6-57ce-4411-bfa1-8b036be90b97)

Company: https://www.keypedia.com/companies/oklahoma-blood-institute-arkansas-blood-institute-north-little-rock/26b203f6-2d43-4eb4-bd07-292b28994e6e

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d